top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antitumor and Anti-HIV Agents from Natural Products
Antitumor and Anti-HIV Agents from Natural Products
Autore Nakagawa-Goto Kyoko
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (338 p.)
Soggetto topico Research & information: general
Soggetto non controllato natural phaeosphaeride A
antitumor activity
human tumor cell lines
HEF cell line
acute toxicity
aspidosperma-type
monoterpenoid indole alkaloids
antiproliferative activity
tubulin inhibitor
Bousigonia mekongensis
ursolic acid
DOTA
triterpenoids
cytotoxicity
diterpenoid alkaloids
human tumor cells
lipojesaconitine
delcosine
delpheline
kobusine
pseudokobusine
BRAF inhibitor
Mentha aquatica var. Kenting Water Mint
essential oil
chemoprevention
two-stage skin carcinogenesis
melanoma
curcumin analog
apoptosis
oxidative stress
drug–drug interaction
tamoxifen
taxol
cisplatin
Artemisia absinthium L.
antioxidants
total phenolic content
melanoma and breast cancer cell line
HaCaT cells
inflammation
breast cancer
cell cycle
flavonoids
reactive oxygen species
tumor suppression
antiretroviral agents
anti-HIV
marine metabolites
natural products
drug development
Ivalin
Carpesium divaricatum
hepatocellular carcinoma
mitochondria-mediated apoptosis
NF-κB
Hernandia nymphaeifolia
butanolides
lignan glycosides
coumarins
antiangiogenic
cancer
natural agents
chemistry
medicine
cancer stem cell
cervical cancer
pterostilbene
resveratrol
caffeic acid
cancer multidrug resistance
P-glycoprotein
phenolic acid
oxypeucedanin
Angelica dahurica
antiproliferation
G2/M phase cell cycle arrest
p53
SK-Hep-1
hepatoma cells
allyl isothiocyanate
benzyl isothiocyanate
sulforaphane
phenethyl isothiocyanate
bladder cancer
quercetin
oral squamous cell carcinoma cells
metastasis
cell cycle arrest
epithelial-to-mesenchymal transition
matrix metalloproteinase
transforming growth factor-β1
β-lapachone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557504803321
Nakagawa-Goto Kyoko  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato antibody drug conjugate (ADC)
PD-L1
tumor spheroid disruption
immune modulation
doxorubicin
graphene oxide
adsorption
cathepsin D
cathepsin L
anti-metastatic enzyme cancer therapy
nanoparticles
targeted delivery system
siRNA
osteopontin
mammary carcinoma
mesenchymal stem cells (MSCs)
TAT peptide
PLGA
paclitaxel
nano-engineered MSCs
orthotopic lung tumor model
intracranial glioma
immunotherapy
CPMV
viral nanoparticles
in situ vaccine
albumin nanoparticles
microbubble
ultrasound
theranostics
hepatocellular carcinoma
VX2 tumor
intra-arterial chemotherapy
lung cancer
nanomedicine
clinical status
cancer therapy
breast cancer
cell signaling
active targeting
passive targeting
EPR effect
oncogenes
nanoparticle
drug delivery
ligand
tumor targeting
biodistribution
Mesoporous silica nanoparticle
drug delivery system
target treatment
lanthanide metal
hyaluronic acid
hyaluronidase
drug combination
everolimus
dual-targeting
magnetic nanoparticles
monoclonal antibodies
nanostructured lipid carrier
platelet membrane
biomimicry
plasmonic photothermal therapy
gold nanorods
surgery
bleeding
dogs
cats
stimuli-responsive
DOX
SN38
CSCs
single-walled carbon nanotubes
chirality separation
NASH
drug-gene delivery
near IR hyperspectral imaging
plasmonics
copper
VEGF
glioblastoma
differentiated neuroblastoma
peptidomimetics
real-time quantitative polymerase chain reaction (qPCR)
actin
combinatorial therapy
anticancer and antibacterial activity
temoporfin
drug-in-cyclodextrin-in-liposome
hybrid nanoparticles
multicellular tumor spheroids
cyclodextrins
photodynamic therapy article
yet reasonably common within the subject discipline
antitumor strategy
biomimetic core–shell nanoparticles
NK cell-derived exosomes
folate receptor
albumin nanoparticle
microfluidic
cabazitaxel
polydopamine nanoparticles
size
cytotoxicity
iron affinity
FA-DABA-SMA
self-assembly
oncogenic proteins
intracellular disruption
folic receptor alpha
pancreatic cancer
parvifloron D
albumin
erlotinib
photodynamic therapy
lipid nanoparticles
tumor vectorization
verteporfin
ovarian carcinomatosis
spheroids
integrin
RGD peptide
cancer diagnosis
radiotherapy
hyperthermia therapy
biomimetic
nanocarrier
membrane-wrapped
cancer
targeted delivery
photothermal therapy
imaging
cancer nanomedicine
tumor microenvironment
nano–bio interactions
clinical translation
magnetic nanowires
magnetic hyperthermia
magnetic actuation
magnetic drug targeting
titanate nanotubes
gold nanoparticles
vectorization
colloidal stability
docetaxel
prostate cancer
mangiferin
anti-topoisomerase activity
extracellular vesicles
exosomes
chemico-physical functionalization
loading
translational medicine
nanotechnology: bioengineering
anacardic acid
mitoxantrone
targeted drug delivery
liposomes
melanoma
apoptosis
ascorbic acid
angiogenesis
epithelial-to-mesenchymal transition
hypoxia
immunosuppression
metabolism
nanotherapeutics
tumour microenvironment
DNA origami
liposome
remote loading
acute toxicity
organoids
magnetic silica-coated iron oxide nanochains
photothermal treatment
hyperthermia
collagen
cellular microenvironment
lymphadenectomy
magnetometer
sentinel lymph node dissection
SPION
superparamagnetic iron oxide nanoparticles
Vδ2 T cells
zoledronic acid
polymeric nanoconstruct
anti-tumor immunity
colorectal carcinoma
β-cyclodextrin nanosponges
BALB-neuT mice
brain tumours
glioma
blood brain barrier
polymeric nanoparticles
PEGylation
dioleoylphosphatidylethanolamine
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
folate
oxidation-sensitive release
cellular interaction
in vitro anti-cancer activity
triple negative breast cancer
organotin
mesoporous silica nanoparticles
MDA-MB-231
theranostic nanomaterials
nanobiotechnology
molecular imaging
nanosystems
nanomicelles
ovarian cancer
tumour targeting
chemotherapeutics
riboflavin
vitamin B2
nanomedicines
secondary structure
mixed micelle
pH responsive
targeted therapy
anti-cancer
shear stress
flow
in vitro
therapeutics
diagnostics
Immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology
Autore Fioravanti Antonella
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (320 p.)
Soggetto topico Medicine
Soggetto non controllato miR-27a-5p
acute myocardial infarction
autophagy
apoptosis
hypoxia
MicroRNA (miRNA)
miR526b
miR655
oxidative stress
reactive oxygen species (ROS)
superoxide (SO)
Thioredoxin Reductase 1 (TXNRD1)
breast cancer
nucleic acid medicine
pancreatic cancer
clinical trial
siRNA
antisense oligonucleotide
MicroRNA
signal transduction
therapeutic target
miRNAs
ROS
noncoding RNA
microRNA
long noncoding RNA
mitochondrial dysfunction
nitrosative stress. exosome
cross-talk
systemic lupus erythematosus
visfatin
resistin
osteoarthritis
synovial fibroblasts
synovitis
NF-κB
thyroid hormone
liver cancer
metabolism
physiology
ASH
NAFLD
NASH
HCC
HCV
HBV
endometriosis
high-grade serous ovarian cancer
endometriosis-associated ovarian cancer
epithelial-to-mesenchymal transition
chemoresistance
antioxidants
miRNA
cancer
diabetes
beta cells
microRNAs
translation regulation
neurodegeneration
Alzheimer's disease
Parkinson's disease
Huntington's disease
ALS
reactive oxygen species
redox signaling
therapeutic tolerance
therapeutic resistance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557526003321
Fioravanti Antonella  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Kidney Inflammation, Injury and Regeneration 2020
Kidney Inflammation, Injury and Regeneration 2020
Autore Baer Patrick C
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (318 p.)
Soggetto topico Medicine
Soggetto non controllato inflammation
chronic kidney disease
anemia
anemia of inflammation
ESA hyporesponsiveness
renal tubular epithelial cells
macrophages
lipocalin-2
iron
cilastatin
hypoxia inducible factor-1-α
ischemia-reperfusion injury
acute kidney injury
cyclophilin A
fibrosis
renal fibrosis
tubular necrosis
preeclampsia
podocytes
VEGF
FSGS
proteinuria
endocan
ESM-1
renal replacement therapy
kidney transplantation
biomarker
diabetic nephropathy
focal segmental glomerulosclerosis
innate immunity
membranous nephropathy
minimal change diseases
TLR
NOX1
ML171
reactive oxygen species
ERK
T cells
glomerulonephritis
chemokines
renal disease
DJ-1
ND-13
renal inflammation
oxidative stress
UUO
autophagy
apoptosis
trehalose
simvastatin
endotoxin
tubular apoptosis
cytochrome C
Bcl-XL
survivin
hypercholesterolemia
xanthine oxidase
NF-κB pathway
tertiary lymphoid organs
B cells
BAFF
kidney fibrosis
myofibroblast activation
extracellular matrix
Hippo pathway
verteporfin
IgAN
CKD
progression
ACEI
corticosteroids
costimulation
coinhibition
kidney transplant
SPR
protein binding affinity
adaptive immunity
epithelial-to-mesenchymal transition
E. cava extracts
dieckol
spontaneously hypertensive rats
angiotensin II
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557364503321
Baer Patrick C  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Metastatic Progression and Tumour Heterogeneity
Metastatic Progression and Tumour Heterogeneity
Autore Hollande Fred
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (312 p.)
Soggetto topico Medicine
Soggetto non controllato clear cell renal cell carcinoma
tumor evolution
tumor ecology
intratumor heterogeneity
multisite tumor sampling
targeted therapy
uterine carcinosarcoma
endometrial carcinoma
metaplastic carcinoma
epithelial-to-mesenchymal transition
clonality
mutation
TP53
PI3K/AKT pathway
gene expression
miRNA expression
tumor microenvironment
interstitial pH
acidosis
tumor heterogeneity
magnetic resonance imaging
hyperpolarized 13C MRI
carbonic anhydrase
lactic acid
positron emission tomography
esophageal squamous cell carcinoma
precision medicine
natural killer cells
tumor mutation burden
immunotherapy
PET
heterogeneity
radiomics
radiopharmaceuticals
SUV
nuclear medicine
colon cancer
Wnt signaling
phenotypic plasticity
EMT
hybrid E/M
collective and single-cell migration
beta-catenin paradox
breast cancer
immune microenvironment
DCIS
ADH
mammary gland
cell fate
3D cultures
organoids
signaling
single-cell RNAseq
tumor endothelial cell
metastasis
angiocrine factor
microsatellite instability
colorectal cancer
immune checkpoints
deficient mismatch repair
plasticity
biomechanics
circulating tumor cells (CTCs)
extracellular vesicles
metastatic niche
epigenetics
CTC-clusters
single-cell analysis
cellular heterogeneity
circulating tumor cells
pancreatic cancer
epithelial mesenchymal plasticity
target discovery
review
genomics
intra-tumour heterogeneity
subclonal diversity
treatment resistance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557105803321
Hollande Fred  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Role of Extracellular Matrix in Cancer Development and Progression
The Role of Extracellular Matrix in Cancer Development and Progression
Autore Tzanakakis George
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (182 p.)
Soggetto topico Research & information: general
Soggetto non controllato elastin
ribosomal protein SA
tongue carcinoma
MMP-2
EGCG
pancreatic ductal adenocarcinoma
syndecans
proteoglycans
tumor progression
angiogenesis
syndecan-4
heparan sulfate
cancer
prognosis
biomarker
signal transduction
proteoglycan
metastasis
extracellular matrix
fibrosis
immune cell modulation
neutrophils
neutrophil extracellular trap
macrophages
BCC
MMP
TIMP
invasion
lumican
cancer cell growth
motility
hyaluronan
RHAMM
CD44
wound repair
breast cancer
malignant pleural mesothelioma
pleural effusion
extracellular vesicles
biomarkers
sulfated hyaluronan
estrogen receptors
epithelial-to-mesenchymal transition
matrix metalloproteinases
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566470803321
Tzanakakis George  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui